A novel BCR-ABL1 fusion gene identified by next-generation sequencing in chronic myeloid leukemia

BACKGROUND: BCR-ABL1 fusion proteins contain constitutively active tyrosine kinases that are potential candidates for targeted therapy with tyrosine kinase inhibitors such as imatinib in chronic myeloid leukemia (CML). However, uncharacterized BCR-ABL1 fusion genes can be missed by quantitative RT-P...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Mol Cytogenet
Huvudupphovsmän: Lyu, Xiaodong, Yang, Jingke, Wang, Xianwei, Hu, Jieying, Liu, Bing, Zhao, Yu, Guo, Zhen, Liu, Bingshan, Fan, Ruihua, Song, Yongping
Materialtyp: Artigo
Språk:Inglês
Publicerad: BioMed Central 2016
Ämnen:
Case Report
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4922057/
https://ncbi.nlm.nih.gov/pubmed/27350795
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13039-016-0257-5
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk